TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Self-reported daytime napping and AD risk
Endpoint domain: Mortality/survival
Primary endpoint: Genital injuries sustained
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Type of injury (abrasions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Location of injury (labia minora)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Adverse events from colonoscopy screening
Endpoint domain: Adverse events/effects
Primary endpoint: reduction in anxiety/depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lower use of hospital and emergency department services
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction in repetitive behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rage
Endpoint domain: Adverse events/effects
Primary endpoint: not rage, not withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Eating Disorder Examination total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of new-onset eating disorder cases
Endpoint domain: Adverse events/effects
Primary endpoint: mean annual cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mental health service use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in performance in the transfusion reaction case
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean value of post‐treatment left NAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total NAR (TNAR) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in probability of overweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in probability of obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difficulty distinguishing target stimuli from distractors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response times consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention sustainability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of post-ERCP pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: MVI status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DFS estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social network size
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Percentage of days in stable housing
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: NSAID-induced gastric ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Olfactory and gustatory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe or life-threatening adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rectal perforation cases
Endpoint domain: Adverse events/effects
Primary endpoint: Device malfunctions
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of developing ES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rates of antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-reported knowledge and confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: simulation effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: MHQ summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Viral load of less than 400 copies per milliliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative peripheral refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial length of young adult myopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood lactate level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: dose of epinephrine within 24 hours after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durable reductions in serum IFNγ protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sputum weight collected over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TcpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Practice of injection safety
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Treg and Breg proportions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient satisfaction with work activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Intentions to seek counseling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction in perceptions of stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improved stress-management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: enhanced self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increase in the number of active voxels on fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2hr OGTT glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: touch thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of the hand in daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: satisfaction with performance in meaningful activities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of imaging requests per 1000 consultations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in symptoms of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CPAP therapy adherence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: score of satisfaction and acceptance of CPAP therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: willingness to continue CPAP therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain VAS improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean patellar width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean patellar thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Wiberg index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PJI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Weight z scores at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head circumference at 36 weeks' PMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length at 36 weeks' PMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of partial crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of material fracture
Endpoint domain: Adverse events/effects
Primary endpoint: Mild to moderate abdominal symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Elevated eosinophil count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Volume loss of crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate of materials
Endpoint domain: Mortality/survival
Primary endpoint: Clinical performance outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DE symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal sodium fluorescein staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of recurrence of ACL ruptures
Endpoint domain: Adverse events/effects
Primary endpoint: KOOS Sport/Rec score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LKS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dynamic Functional Connectivity (DFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adjustment time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: adjustment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: willingness-to-pay
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Single-leg stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular damage area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: self-management behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Relative bioavailability (RBV) of FeFum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FAFe levels in mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FAFe levels in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cured time of sunburns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow velocities in middle-cerebral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mixed anxiety and depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faecal continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cyberbullying victimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: marijuana use frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of Baby Steps app on lifestyle changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: GDM self-management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of the Baby Steps app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical improvement at day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality by day 15 and day 29
Endpoint domain: Mortality/survival
Primary endpoint: Concordance for total difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concordance for total impact
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative analgesia measured by NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days of oxygen treatment to keep saturation above 93%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IL17A, IFNγ and IL10 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the curve for distinguishing gout from asymptomatic hyperuricemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extubation time after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-HBs positive rate (≥10 mIU/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: strong positive rate (≥100 mIU/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GOHAI score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall diet quality on the Alternative Health Eating Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcomes (RMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean fibroma thickness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in SODA score for pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SODA score for non-pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EQ-5D index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: caregiver preparedness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnosis of HIV infection
Endpoint domain: Mortality/survival
Primary endpoint: Acute HIV infection (AHI) diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: LCQ score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough VAS score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough frequency change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VJH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fraction of circulating natural killer cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pro-inflammatory cytokine levels (IL-12p70)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: abdominal distension reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in treatment plans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in corneal staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Take rate of skin grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Dressing time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean PRWE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to continence
Endpoint domain: Mortality/survival
Primary endpoint: Insertion torque values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield in the detection of arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes towards suicidal behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: executive function performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: instrumental activities of daily living performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: head aBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of combined scenario scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements identified by the Minnesota living with heart failure questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with depression who had a behavioral health visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with anxiety who had a behavioral health visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with both disorders who had a behavioral health visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in CDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal anterior horn cell excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPV vaccine initiation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPV vaccine completion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced access to naloxone and sterile syringes
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean visual analogue pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMN amplitude reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment difference versus placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax and AUClast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discordant pattern of high ESR and normal CRP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discordant pattern of high CRP and normal ESR values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overbite difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable functional outcome (mRS 0-3)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of adequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients without analgesic rescue medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term survival of patients without rescue analgesic
Endpoint domain: Mortality/survival
Primary endpoint: Referral to and completion of ABPM and HBPMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACT-Cog
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Interstitial oedema in dorsal lung regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IL-8 concentration in lung tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diaphragmatic muscle fibre diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: risk for first hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: all hospitalizations or death
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial-image scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mortality after CEA and CAS
Endpoint domain: Mortality/survival
Primary endpoint: Prolonged length of stay (LOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention at 3-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Past-month HDEs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean mMASI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-report physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Use of oral anticoagulants (OAC)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: LPP amplitudes in response to emotional and drug-related cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term risk of CIN3+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Knowledge regarding nutrition and reproductive health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes towards nutrition and reproductive health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Practices regarding nutrition and reproductive health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lower pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower qDASH
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: time to develop late AMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DSST improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stroop improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning